These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8808252)

  • 1. Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure.
    Svára F; Spicka I; Sulková S; Zabka J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2374-5. PubMed ID: 8808252
    [No Abstract]   [Full Text] [Related]  

  • 2. r-HuEPO treatment of anemia associated with multiple myeloma and ESRD.
    Van der Niepen P; Sennesael J; Verbeelen D
    Clin Nephrol; 1993 Feb; 39(2):113. PubMed ID: 8448915
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.
    Taylor J; Mactier RA; Stewart WK; Henderson IS
    BMJ; 1990 Sep; 301(6750):476-7. PubMed ID: 2207402
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant human erythropoietin in a patient with multiple myeloma and end-stage renal disease.
    Holley JL; Nolan TA; Piraino B
    Clin Nephrol; 1992 Mar; 37(3):145-7. PubMed ID: 1563119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recombinant human erythropoietin in the treatment of the anemia of multiple myeloma with kidney failure].
    Arenas Gracia M; Abad Gosálvez A; Colomina Avilés J; Pascual Pérez R; Ferriz Moreno P
    An Med Interna; 1995 Apr; 12(4):187-8. PubMed ID: 7620064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of erythropoietin to treat anaemia in end-stage renal disease.
    Ellis P; Ellis JA
    Prof Nurse; 1995 Apr; 10(7):448-50. PubMed ID: 7724635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J; Koch KM
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?
    Caillette A; Barreto S; Gimenez E; Labeeuw M; Zech P
    Clin Nephrol; 1993 Sep; 40(3):176-8. PubMed ID: 8403574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure.
    Morris KP; Skinner JR; Hunter S; Coulthard MG
    Arch Dis Child; 1993 May; 68(5):644-8. PubMed ID: 8323333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)].
    Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A
    Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
    Wiecek A; Kokot F; Grzeszczak W; Klin M
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma and renal failure.
    Goldschmidt H; Lannert H; Bommer J; Ho AD
    Nephrol Dial Transplant; 2000 Mar; 15(3):301-4. PubMed ID: 10692511
    [No Abstract]   [Full Text] [Related]  

  • 17. Current and potential applications for erythropoietin.
    Pedrazzini A
    Acta Haematol; 1992; 87 Suppl 1():2-3. PubMed ID: 1574962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
    Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal route of administration of erythropoietin in chronic renal failure patients: intravenous versus subcutaneous.
    Hörl WH
    Acta Haematol; 1992; 87 Suppl 1():16-9. PubMed ID: 1574961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
    Howarth JE; Waters HM; Shanks D; Hyde K; Yin JA; Geary CG; Anastassiades E; Howarth D; Gokal R
    J Clin Pathol; 1993 Jan; 46(1):41-4. PubMed ID: 8432886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.